Skip to main content
Patrick Loehrer Sr., MD, Oncology, Indianapolis, IN

PatrickJLoehrerSr.MD

Oncology Indianapolis, IN

Gastrointestinal Cancer, Hematologic Oncology

Professor, Oncology, Indiana University School of Medicine

Dr. Loehrer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Loehrer's full profile

Already have an account?

  • Office

    535 Barnhill Dr
    # ROUTE448
    Indianapolis, IN 46202
    Phone+1 317-278-7418

Summary

  • I am a board certified medical oncologist specializing in Gastrointestinal and thymic malignancies. I also am involved with global oncology

Education & Training

  • Indiana University School of Medicine
    Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1981 - 1983
  • Rush University Medical Center
    Rush University Medical CenterResidency, Internal Medicine, 1978 - 1980
  • Rush Medical College of Rush University Medical Center
    Rush Medical College of Rush University Medical CenterClass of 1978

Certifications & Licensure

  • IN State Medical License
    IN State Medical License 1981 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2006-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Indianapolis Monthly Castle Connolly, 2010-2011, 2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Cardiovascular Risk Factors Play Greater Role in Adverse Outcomes in Thymic Cancer Patients
    Cardiovascular Risk Factors Play Greater Role in Adverse Outcomes in Thymic Cancer PatientsFebruary 25th, 2025
  • Empowering People with Cancer: A Q&A with Cancer.Net Editor in Chief Dr. Jyoti Patel
    Empowering People with Cancer: A Q&A with Cancer.Net Editor in Chief Dr. Jyoti PatelJune 8th, 2021
  • Once-Trumpeted $150M Simon Cancer Center to Be Empty by 2026
    Once-Trumpeted $150M Simon Cancer Center to Be Empty by 2026September 12th, 2020
  • Join now to see all

Grant Support

  • The East Africa Consortium for HPV and Cervical Cancer in Women living with HIV/AIDSINDIANA UNIVERSITY INDIANAPOLIS2020–2025
  • Eastern Cooperative Oncology GroupNational Cancer Institute1994–2012
  • Indiana University Melvin And Bren Simon Cancer Center Support GrantNational Cancer Institute2008–2011
  • Usa/Japan--Oral Uracil/Ftorafur+ Leucovorin In ColorectaNational Center For Research Resources2000–2002
  • Perillyl Alcohol In Resectable Pancreatic CancerNational Center For Research Resources2000–2002
  • LY231514 (Thymidylate Synthase Inhibitor) With Pancreatic CancerNational Center For Research Resources1996–1997

Professional Memberships